Non-HDL Cholesterol: What a Normal LDL Does Not Show

Non-HDL cholesterol rarely appears as a separate request, because the laboratory has nothing extra to do for it. It takes your total cholesterol and removes your HDL cholesterol from it. What is left is the cholesterol inside every particle carrying apolipoprotein B: LDL, IDL, VLDL, the remnants formed after a fat-rich meal, and Lp(a).

Each of those particles carries exactly one apoB molecule, and each of them can enter the artery wall. HDL does the opposite and ferries cholesterol back to the liver. The subtraction therefore separates two directions of travel, not merely two numbers.

Why that can matter to you only becomes visible once you put two reports side by side. The calculated LDL on a Dutch lipid panel almost always comes out of the Friedewald formula, which estimates LDL by taking a portion of the triglyceride value off the non-HDL: that value divided by 2.2. The higher your triglycerides, the more is taken off and the lower your LDL lands, without a single particle having disappeared.

Two men of forty-five, the same total cholesterol, the same calculated LDL, and yet a profile that is not the same at all.

Man B has nothing more favourable about him than man A, yet his calculated LDL suggests otherwise. His non-HDL sits 0.8 mmol/l higher, and that gap consists entirely of the VLDL and remnant particles the triglycerides bring along. Those particles count towards non-HDL and fall outside LDL. For a man whose waist has shifted outwards over recent years, this is not an invented scenario but the most ordinary pattern there is.

None of it costs anything extra either. Total cholesterol and HDL are already on every lipid panel, so the number is sitting there ready; it is simply not always worked out for you. ApoB counts the particles themselves and is a shade purer still, but has to be requested separately. Non-HDL is the version always within reach.

Fat tissue around the organs behaves differently from fat under the skin. It releases free fatty acids straight to the liver, and the liver answers by producing more VLDL: triglyceride-rich particles that each carry an apoB molecule. Under insulin resistance that production climbs further, because insulin then restrains VLDL output less effectively.

From that point the whole profile shifts in a predictable way. The VLDL particles swap triglycerides en route for cholesterol out of HDL and LDL particles. Your HDL drops as a result, your LDL particles turn smaller and denser, and a procession of remnants is left behind. Little of this shows on the report: the LDL figure can stay perfectly tidy while your triglycerides run to 2.5 or 3.0 mmol/l. Non-HDL counts that whole procession and therefore rises.

That men meet this pattern more often is no coincidence. Men store fat around the organs sooner than under the skin, and their HDL sits on average some 0.2 to 0.3 mmol/l lower than a woman's. At the same total cholesterol, a man's non-HDL therefore comes out higher before anything unusual is going on. Cardiovascular risk also rises roughly ten years earlier in men than in women, which means the same value at the same age carries different weight.

The hormonal side belongs here honestly, limits included. A lower testosterone travels statistically with more visceral fat, higher triglycerides and a lower HDL, and that combination pushes non-HDL exactly the wrong way. Which way the arrow points is unsettled: abdominal fat lowers testosterone and a lower testosterone makes abdominal fat easier to accumulate, most likely both at once. What you may not conclude from it is that hormone treatment repairs a lipid profile. That is a conversation with a doctor and not a deduction from a result.

Meanwhile non-HDL is anything but a marginal figure. SCORE2, the European risk model written into the prevention guideline since 2021, works with this number and not with LDL. Your age, sex, smoking and systolic pressure go into it, and of your lipids only the non-HDL.

So how high may non-HDL cholesterol be? No answer holds for everyone. The European dyslipidaemia guideline ties the target to your risk category, setting it 0.8 mmol/l above the corresponding LDL target every time.

Take that 3.5 mmol/l seriously as an example, because it is a value many men come home with. At moderate risk you sit just above the goal and there is room to work on your waist and your triglycerides. At high risk the very same 3.5 stands almost a whole mmol/l away from target. The number has not changed, only the context around it. Which category applies to you is your doctor's judgement, based on your age, blood pressure, smoking, blood sugar, family history and any earlier vascular trouble.

And the 3.3 mmol/l the laboratory prints? It describes what is usual in the population. That it happens to land close to the moderate-risk goal makes it treacherous: at a higher risk your report looks entirely normal while you sit comfortably above your own target. So read your risk profile first and the number second. If an ApoB also appears on your report, that is the purer particle measure; where the two diverge, ApoB wins.

You do not have to request non-HDL separately. Any lipid panel delivers it on its own, because the two values it needs are already there. Nor do you have to fast: across the whole panel only the triglyceride value truly responds to food, and that value does not enter the subtraction.

The number becomes more interesting as your waist grows. If your waistline has widened over recent years, if your triglycerides are raised, or if the sample was drawn non-fasting, then the non-HDL on that same report is more trustworthy than the LDL beside it. Should your triglycerides come back above roughly 4.5 mmol/l, the calculated LDL is no longer usable at all and the panel should be repeated fasting.

Many men have their lipids measured for the first time only around forty. Starting earlier is sensible when cardiovascular disease appeared young in your family, when your blood pressure or blood sugar already asks for attention, or when you smoke.

Do not test in the middle of an illness or shortly after one. Following an infection, surgery or a heart attack, cholesterol values sink for weeks, so the profile underestimates your usual level. Give yourself a few weeks after recovery before testing again.

A single measurement remains a snapshot. Within one person, total cholesterol swings by five to ten percent from day to day and the triglyceride value by twenty to twenty-five. A difference of 0.2 mmol/l between two results therefore says nothing. If you want to follow the line across the years, choose the same laboratory each time.

If your non-HDL comes back unexpectedly high, look first for a cause outside your lifestyle. An underactive thyroid heads that list and is regularly missed, so have your TSH run alongside it. Poorly controlled diabetes, kidney and liver disease, cholestasis, heavy alcohol use and a range of medicines can disturb the profile too, among them corticosteroids, thiazide diuretics, some beta blockers and the use of androgens. That is material for your doctor, not a puzzle to solve on your own.